Replies to post #17032 on Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Thales622]

Well thats exactly it. Professionals need to show monthly performance in their P&L's. Short term wise $STSI hasn't got anything going for it.

Do you know how long it takes and how much money it takes to get a drug through phase 1-3 trials? It can take somewhere between 7-10 years. It costs a lot of money to do it as well.

So all you guys that think they can make it with an IND, why not look to see how long that takes and how much it costs and ask where the money is going to come from? They will have to dilute and that will kill the price.

So just explain to me how they are going to run a company without any income (if it comes to that) and how much it will cost to do so?

Another thing, no pro is going to go into this stock in size unless they pass these trials. So if it comes to that *nothing* will lift the price for years.

In short: $STSI doesn't have a business angle because they don't have a business.

You need to ask yourself should I invest in something that has no return or wait until it has a chance of making a return. All you longs are confusing the product with the business, the product is excellent, the business is worthless.